Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy

被引：0

作者：

Lebkowski, Jane S. ^{[1
]}

Khoury, Hanna J. ^{[2
]}

Collins, Robert H. ^{[3
]}

Blum, William ^{[4
]}

Stiff, Patrick ^{[5
]}

Wirth, Edward ^{[6
]}

Nishimoto, Kevin ^{[6
]}

DiPersio, John ^{[7
]}

机构：

[1] Asterias Biotherapeut, Portola Valley, CA USA

[2] Emory Univ, Atlanta, GA 30322 USA

[3] UT Southwestern, Dallas, TX USA

[4] Ohio State Univ, Columbus, OH 43210 USA

[5] Loyola Univ, Maywood, IL 60153 USA

[6] Asterias Biotherapeut, Fremont, CA USA

[7] Washington Univ, St Louis, MO USA

来源：

MOLECULAR THERAPY | 2016年 / 24卷

关键词：

D O I：

10.1016/S1525-0016(16)33085-4

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

276

引用

页码：S110 / S110

页数：1

共 50 条

[1] LONG-TERM RELAPSE-FREE SURVIVAL IN CHILDHOOD ACUTE NONLYMPHOCYTIC LEUKEMIA
LIE, SO
SLORDAHL, SH
SEMINARS IN ONCOLOGY, 1987, 14 (02) : 7 - 11
[2] LONG-TERM RELAPSE-FREE SURVIVAL IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA
GINGRICH, RD
BURNS, CP
ARMITAGE, JO
AUNAN, SB
EDWARDS, RW
DICK, FR
MAGUIRE, LC
LEIMERT, JT
CANCER TREATMENT REPORTS, 1985, 69 (02): : 153 - 160
[3] Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells
Curti, Antonio
Ruggeri, Loredana
Parisi, Sarah
Bontadini, Andrea
Dan, Elisa
Rizzi, Simonetta
Motta, Maria Rosa
Trabanelli, Sara
Ocadlikova, Darina
Lecciso, Mariangela
Giudice, Valeria
Urbani, Elena
Papayannidis, Cristina
Martinelli, Giovanni
Bonifazi, Francesca
Bandini, Giuseppe
Fruet, Fiorenza
Lewis, Russel E.
Cavo, Michele
Velardi, Andrea
Lemoli, Roberto M.
BLOOD, 2014, 124 (21)
[4] Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients With Acute Myeloid Leukemia
Khoury, Hanna J.
Collins, Robert H., Jr.
Blum, William
Stiff, Patrick S.
Elias, Laurence
Lebkowski, Jane S.
Reddy, Anita
Nishimoto, Kevin P.
Sen, Debasish
Wirth, Edward D., III
Case, Casey C.
DiPersio, John F.
CANCER, 2017, 123 (16) : 3061 - 3072
[5] LONG-TERM SURVIVAL IN REMISSION OF ADULT ACUTE MYELOID-LEUKEMIA (AML) PATIENTS
RUVIDIC, R
BOSKOVIC, D
TOMIN, D
ELEZOVIC, I
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1992, 34 (03): : 277 - 277
[6] High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)
Graf, M
Reif, S
Hecht, K
Pelka-Fleischer, R
Kroell, T
Pfister, K
Schmetzer, H
ANNALS OF HEMATOLOGY, 2005, 84 (05) : 287 - 297
[7] High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)
M. Graf
S. Reif
K. Hecht
R. Pelka-Fleischer
T. Kroell
K. Pfister
H. Schmetzer
Annals of Hematology, 2005, 84 : 287 - 297
[8] IMPACT OF MOLECULAR MARKERS AND CYTOGENETIC ABNORMALITIES ON LONG-TERM OVERALL SURVIVAL AND DISEASE FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS
Michallet, M.
Sobh, M.
Barraco, F.
Nicolini, F. E.
Dumontet, C.
Chelghoum, Y.
Cannas, G.
Nicolas-Virelizier, E.
Plesa, N.
Ducastelle, S.
Troncy, J.
Thomas, X.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 342 - 342
[9] Increased γδT cells are associated with a long-term relapse-free survival following allogeneic BMT for acute leukemia.
Lamb, LS
Godder, K
Musk, P
Neuberg, R
Chaing, KY
Abhyankar, S
Bridges, K
King, KM
Muga, SJ
Volate, SR
Henslee-Downey, PJ
BLOOD, 2002, 100 (11) : 335A - 336A
[10] Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine
Khoury, Hanna Jean
Collins, Robert
Blum, William G.
Stiff, Patrick J.
Lebkowski, Jane
Wirth, Edward
Nishimoto, Kevin
DiPersio, John F.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →